These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 25776138)

  • 21. Technical risks with subcutaneous insulin infusion.
    Guilhem I; Leguerrier AM; Lecordier F; Poirier JY; Maugendre D
    Diabetes Metab; 2006 Jun; 32(3):279-84. PubMed ID: 16799407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy.
    Waldenmaier D; Zschornack E; Kalt L; Buhr A; Pleus S; Haug C; Freckmann G
    J Diabetes Sci Technol; 2019 Jan; 13(1):96-102. PubMed ID: 29998760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous subcutaneous insulin infusion: Special needs for children.
    Adolfsson P; Ziegler R; Hanas R
    Pediatr Diabetes; 2017 Jun; 18(4):255-261. PubMed ID: 28425167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump.
    Thrasher J; Surks H; Nowotny I; Pierre S; Rotthaeuser B; Wernicke-Panten K; Garg S
    J Diabetes Sci Technol; 2018 May; 12(3):680-686. PubMed ID: 29359575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
    Hoogma RP; Schumicki D
    Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.
    Ponder SW; Skyler JS; Kruger DF; Matheson D; Brown BW
    Diabetes Educ; 2008; 34(2):327-33. PubMed ID: 18375782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rediscovery of insulin pump treatment of childhood type 1 diabetes.
    Weinzimer SA; Doyle EA; Steffen AT; Sikes KA; Tamborlane WV
    Minerva Med; 2004 Apr; 95(2):85-92. PubMed ID: 15272243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.
    Cescon M; DeSalvo DJ; Ly TT; Maahs DM; Messer LH; Buckingham BA; Doyle FJ; Dassau E
    J Diabetes Sci Technol; 2016 Nov; 10(6):1268-1276. PubMed ID: 27621142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AADE position statement: education for continuous subcutaneous insulin infusion pump users. American Association of Diabetes Educators.
    Diabetes Educ; 1997; 23(4):397-8. PubMed ID: 9305004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia.
    Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
    Ronquillo JG; Zuckerman DM
    Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-reported experience with Velosulin human insulin in continuous subcutaneous insulin infusion.
    Marcus A; Bode B; Drexler A; Etkind E; Koch MM; Liljenquist JE; McCulloch DK; Strowig SM; Tanenberg RJ
    Clin Ther; 1995; 17(2):204-13. PubMed ID: 7614521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year food and drug administration retrospective study of adverse events.
    Scaramuzza A; Iafusco D; Lombardo F; Rabbone I; Toni S;
    Pediatrics; 2008 Aug; 122(2):473-4; author reply 474. PubMed ID: 18676571
    [No Abstract]   [Full Text] [Related]  

  • 36. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents.
    Ziegler R; Waldenmaier D; Kamecke U; Mende J; Haug C; Freckmann G
    Pediatr Diabetes; 2020 Jun; 21(4):649-656. PubMed ID: 32003490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of diabetes with the insulin pump].
    Koznarová R; Jirkovská A; Pelikánová T
    Cas Lek Cesk; 2001 Apr; 140(8):227-9. PubMed ID: 11392038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review.
    Bonato L; Taleb N; Gingras V; Messier V; Gobeil F; Ménard J; Ardilouze JL; Rabasa-Lhoret R
    Diabetes Technol Ther; 2018 Jul; 20(7):506-515. PubMed ID: 29958025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.